FIELD: medicine, infectious diseases. SUBSTANCE: method of treatment of patients with erysipelas involves the use of lyncomycin as an etiotropic agent and additional course intravenous administration of autoblood hemolyzate by 20 ml. Infusions are carried out every day for 10 days at acute disease period and then repeated for the next year every 2-3 months but at shorter course, by 5-6 every day infusions. EFFECT: enhanced antirelapse activity of lyncomycin, decreased allergic responses to lyncomycin. 1 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RECURRENT ERYSIPELAS PREVENTION METHOD | 2007 |
|
RU2354144C1 |
| AGENT FOR TREATMENT LIMBS ERYSIPELAS | 1995 |
|
RU2096039C1 |
| METHOD FOR DETECTING THE MERIT FOR PRESCRIBING EMOXYPIN FOR ERYSIPELAS-SUFFERING PATIENTS | 2003 |
|
RU2232995C1 |
| METHOD FOR PREDICTING CHRONIC RELAPSING DISEASE COURSE IN PERSONS RECOVERED FROM PRIMARY ERYSIPELAS | 1995 |
|
RU2101701C1 |
| METHOD FOR PREDICTING EARLY ERYSIPELAS RECURRENCE CASES | 1999 |
|
RU2144191C1 |
| METHOD OF TREATING PATIENTS WITH PYOINFLAMMATORY SKIN DISEASES | 2009 |
|
RU2423976C2 |
| METHOD FOR PREVENTING THROMBOCYTOPENIA IN PATIENTS WITH CHRONIC HEPATITIS C AND RECEIVING COMBINATION ANTIVIRAL THERAPY | 2014 |
|
RU2568593C1 |
| METHOD FOR PREVENTION OF NEUTROPENIA IN PATIENTS SUFFERING CHRONIC HEPATITIS C AND RECEIVING ANTIVIRAL COMBINATION THERAPY | 2014 |
|
RU2568894C1 |
| METHOD FOR PREDICTING BULLOUS AND HEMORRHAGIC FORMS OF ERYSIPELAS | 1999 |
|
RU2148258C1 |
| METHOD FOR PREDICTION OF HEMORRHAGIC FORMS OF DISEASE DEVELOPING IN PATIENTS, SUFFERING FROM ERYSIPELAS OF LOWER EXTREMITIES | 2015 |
|
RU2601370C1 |
